Bioinformatics Market Report Scope & Overview:

The Bioinformatics Market size is estimated at USD 23.05 billion in 2025 and is expected to reach USD 91.95 billion by 2035, growing at a CAGR of 14.84% over the forecast period of 2026-2035.

The global bioinformatics market trend is a growing demand for computational biology solutions such as genomic data analysis platforms, molecular modeling software, and next-generation sequencing data interpretation tools as the growth of the market is driven by increasing genomic research initiatives, precision medicine adoption, and pharmaceutical drug discovery acceleration. This trend is also driven by a growing adoption of artificial intelligence in biological data analysis and the growing focus on personalized healthcare as research organizations become more focused on understanding complex biological systems and are more willing to invest in advanced computational technologies, resulting in growth in the domestic and international market for cloud-based and on-premise bioinformatics platforms.

For instance, in March 2024, growing awareness and improved research infrastructure drove a 31% increase in bioinformatics platform adoption for academic and pharmaceutical research institutions globally, boosting genomic data analysis capabilities and accelerating drug discovery timelines.

Bioinformatics Market Size and Forecast:

• Market Size in 2025: USD 23.05 billion

• Market Size by 2035: USD 91.95 billion

• CAGR: 14.84% from 2026 to 2035

• Base Year: 2025

• Forecast Period: 2026–2035

• Historical Data: 2022–2024

To Get more information On Bioinformatics Market - Request Free Sample Report

Bioinformatics Market Trends

• Bioinformatics solutions are being adopted because researchers demand advanced genomic sequencing analysis, protein structure prediction, and high-throughput biological data processing capabilities.

• Customized computational biology tools based on research domains, organism types, and analysis workflows to improve scientific discovery outcomes.

• The development of machine learning-powered sequence alignment, deep learning-based protein folding prediction, and automated pathway analysis to improve the accuracy of biological insights and reduce computational processing time.

• Integrated workflow management systems, real-time collaboration platforms, and scalable data storage solutions are all available to ensure continuous research progression and reproducible scientific results.

• Increased demand for cloud-based bioinformatics platforms, containerized analysis pipelines and distributed computing resources to help computational scalability and data accessibility.

• Collaboration between pharmaceutical companies, academic research institutions and biotechnology firms to develop integrated bioinformatics ecosystems and improve data standardization protocols.

• FDA, NIH and international genomic consortia promoting standards for data quality, FAIR data principles, open-source tool development, and computational reproducibility requirements.

The U.S. Bioinformatics Market is estimated at USD 9.34 billion in 2025 and is expected to reach USD 37.25 billion by 2035, growing at a CAGR of 14.98% from 2026-2035. The United States represents the largest market for bioinformatics, primarily driven by the extensive genomic research funding, federal initiatives supporting precision medicine, and well-developed biotechnology research infrastructure. Government grants, high levels of pharmaceutical research and development investment, and increased academic institution spending on computational biology help to drive growth in the market. Also, the U.S. is the largest regional market in the world, due to the research excellence and swift adoption of cloud-based and AI-powered bioinformatics solutions.

Bioinformatics Market Growth Drivers:

• Next-Generation Sequencing Technology Advancement is Driving the Bioinformatics Market Growth

Next-generation sequencing technology advancement takes the center stage as a growth driver for the bioinformatics market share, and are driven by the implementation of whole genome sequencing projects, transcriptome profiling initiatives, and single-cell sequencing applications for increased biological data generation and computational analysis requirements. These solutions for genomic data interpretation and variant annotation are driving the base of the market, the penetration of cloud-based & knowledge management markets, and adding to the overall market share globally.

For instance, in June 2024, cloud-based and integrated bioinformatics platforms accounted for ~71% of the total global genomic research technology investments, reflecting growing institutional preference and expanding market share.

Bioinformatics Market Restraints:

• Data Standardization Challenges and Interoperability Issues are Hampering the Bioinformatics Market Growth

Data standardization challenges & interoperability issues of bioinformatics systems also restrict the bioinformatics market growth, as a large number of research organizations face difficulties integrating heterogeneous biological databases and ensuring consistent data formats across different analytical platforms. This might lead to reduced collaboration efficiency, limited data sharing, and decreased research reproducibility for computational biology projects. As a result, scientific discovery outcomes suffer, and market growth is stunted in regions where standardized bioinformatics infrastructure is limited and specialized computational expertise is scarce.

Bioinformatics Market Opportunities:

• Artificial Intelligence Integration and Machine Learning Applications Drive Future Growth Opportunities for the Bioinformatics Market

The opportunity in the artificial intelligence integration and machine learning applications in bioinformatics market is in the form of predictive protein structure modeling, automated gene function annotation, and intelligent drug-target interaction prediction. These solutions provide for accelerated drug discovery processes, individualized treatment strategy development, and real-time genomic variant interpretation. Through enhanced research productivity, clinical decision support enhancement, and pharmaceutical development cost reduction, particularly in areas with precision medicine implementation needs, these technologies may improve patient outcomes, decrease therapeutic development timelines, and expand the market.

For instance, in April 2024, the NIH reported that 76% of major research institutions implemented AI-driven bioinformatics platforms, highlighting rising technology adoption and increasing demand for intelligent computational biology tools.

Bioinformatics Market Segment Analysis

• By product & services, bioinformatics platforms held the largest share of around 49.72% in 2025E, and the knowledge management tools segment is expected to register the highest growth with a CAGR of 15.34%.

• By application, the genomics segment dominated the market with approximately 42.18% share in 2025E, while the metabolomics is expected to register the highest growth with a CAGR of 16.12%.

• By sector, medical biotechnology accounted for the leading share of nearly 58.46% in 2025E, and is expected to register the highest growth with a CAGR of 15.23%.

By Product & Services, Bioinformatics Platforms Lead the Market, While Knowledge Management Tools Register Fastest Growth

The bioinformatics platforms segment accounted for the highest revenue share of approximately 49.72% in 2025, owing to comprehensive workflow integration capabilities, scalable computational infrastructure, and extensive analytical tool libraries. Emerging trends, including increasing requirements for end-to-end research solutions and institutional preference for unified analysis environments. In comparison, the knowledge management tools segment is anticipated to achieve the highest CAGR of nearly 15.34% during the 2026–2035 period, driven by the increasing demand for efficient data organization systems, literature mining capabilities, and collaborative research platforms. Drivers include rising biological database complexity, the preference for intelligent information retrieval systems.

By Application, the Genomics Segment dominates, while the Metabolomics Segment Shows Rapid Growth

By 2025, the genomics segment contributed the largest revenue share of 42.18% due to extensive whole genome sequencing adoption, personalized medicine initiatives and cancer genomics research expansion. Growing implementation of population genomics studies coupled with decreasing sequencing costs, research institutions are increasingly investing in genomic analysis capabilities. The metabolomics segment is projected to grow at the highest CAGR of about 16.12% between 2026 and 2035 due to the growing need for metabolic pathway analysis and biomarker discovery applications. Some of the reasons include enhanced understanding of disease mechanisms, better drug metabolism prediction, and pharmaceutical companies' preference for comprehensive metabolic profiling systems.

By Sector, Medical Biotechnology Leads, and Registers Fastest Growth

The medical biotechnology segment accounted for the largest share of the bioinformatics market with about 58.46%, owing to its clinical diagnostics applications, therapeutic development requirements, and precision medicine implementation. Reasons driving the medical biotechnology segment include increasing cancer research initiatives and rare disease investigation needs. In addition, it is slated to grow at the fastest rate with a CAGR of around 15.23% throughout the forecast period of 2026–2035, as hospitals, pharmaceutical companies, and clinical research organizations seek comprehensive genomic analysis platforms, drug-target identification tools, and patient stratification capabilities. Increased focus on companion diagnostics development and personalized treatment optimization contribute to their adoption, while improved clinical trial design and reduced drug development costs drive continued investment.

Bioinformatics Market Regional Highlights:

Get Customized Report as per Your Business Requirement - Enquiry Now

Asia Pacific Bioinformatics Market Insights:

Asia Pacific is the fastest-growing segment in the bioinformatics market with a CAGR of 16.42%, as the awareness about computational biology applications, government genomic research initiatives, and biotechnology sector expansion in developing nations is growing. Factors including rapid academic research infrastructure development, rising pharmaceutical outsourcing with bioinformatics support needs, and growing adoption of personalized medicine approaches are stimulating the market growth. Contract research organization establishment and genomic sequencing facility expansion have been instrumental in improving computational analysis capabilities, especially in countries with emerging life sciences industries. Public health genomics programs and research funding increases also help in advancing bioinformatics infrastructure and talent development. Increase in demand in Asia Pacific region owing to rising healthcare research expenditure against historical spending levels and growing affordability and accessibility of cloud-based computational biology platforms.

North America Bioinformatics Market Insights:

North America held the largest revenue share of over 40.52% in 2025 of the bioinformatics market due to an established biotechnology research environment, substantial NIH and NSF funding mechanisms, and increased pharmaceutical company investment in computational drug discovery. Drivers include ubiquitous use of next-generation sequencing technologies, an advanced high-performance computing infrastructure, growing precision medicine adoption and greater acceptance of AI-driven biological data analysis stemming from research excellence. At the same time, various government genomic initiatives, Cancer Moonshot program implementation and enormous investments in bioinformatics research from academic institutions and pharmaceutical companies are anchoring bioinformatics software and services in the market, and ensuring multibillion dollar revenues around the world.

Europe Bioinformatics Market Insights:

The bioinformatics market in Europe is the second-dominating region after North America on account of an increase in the adoption of European Bioinformatics Institute resources, robust collaborative research networks including ELIXIR infrastructure, and increasing genomic medicine integration initiatives across healthcare systems. Rising implementation of Horizon Europe research funding, advanced computational biology training programs, favorable government support for open-source bioinformatics development, and cross-border research collaboration frameworks are also contributing to the sustained growth of the market in leading European countries.

Latin America (LATAM) and Middle East & Africa (MEA) Bioinformatics Market Insights:

In Latin America, and Middle East & Africa, the growing biotechnology sector development and increase in research infrastructure investment with genomic sequencing facility establishment support the bioinformatics market growth. The rising popularity of affordable cloud-based computational platforms and international research partnership capabilities, along with genomic diversity research initiatives, will aid scientific discovery and regional research capacity building. The increasing university bioinformatics programs and improving computational infrastructure in these regions are continuing to encourage market growth.

Bioinformatics Market Competitive Landscape:

Illumina, Inc. (est. 1998) is a leading biotechnology company that focuses on integrated genomic sequencing solutions and data analysis platforms for research and clinical applications. It uses its comprehensive sequencing technology portfolio and analytical software expertise to produce cutting-edge bioinformatics solutions with seamless laboratory workflow integration.

• In February 2025, it expanded its DRAGEN platform capabilities with enhanced AI-driven variant interpretation and automated genomic report generation, aiming to improve clinical genomics accuracy and analysis turnaround time across its global customer network.

Thermo Fisher Scientific Inc. (est. 1956) is a well-known global life sciences company focused on analytical instruments, laboratory equipment, and bioinformatics software solutions. It invests in comprehensive data management platforms and cloud-based analysis applications with the hopes of revolutionizing scientific research with secure, scalable, and integrated computational biology tools.

• In May 2024, launched an enhanced cloud-native bioinformatics suite featuring real-time collaboration capabilities and integrated multi-omics analysis workflows across pharmaceutical and academic research markets, enhancing data integration, computational efficiency, and research reproducibility.

QIAGEN N.V. (est. 1984) is a leading molecular diagnostics and sample preparation technology provider in the fields of genomic analysis, bioinformatics software development, and precision medicine solutions. The company's bioinformatics product portfolio focuses on intuitive user interfaces and clinical interpretation engines, and features a strong commitment to regulatory compliance and continuous innovation to complement the strong market presence in both research and clinical diagnostic settings.

• In September 2024, introduced advanced clinical genomics interpretation and automated biomarker discovery features for its QIAGEN Digital Insights platform, strengthening precision medicine capabilities and expanding adoption among clinical laboratories and pharmaceutical companies.

Bioinformatics Market Key Players:

• Illumina, Inc.

• Thermo Fisher Scientific Inc.

• QIAGEN N.V.

• Agilent Technologies, Inc.

• PerkinElmer, Inc.

• Dassault Systèmes (BIOVIA)

• BGI Genomics

• Eurofins Scientific

• Oxford Nanopore Technologies

• Pacific Biosciences (PacBio)

• F. Hoffmann-La Roche Ltd (Genentech)

• Waters Corporation

• Bio-Rad Laboratories, Inc.

• Bruker Corporation

• Partek Incorporated

• DNAnexus, Inc.

• Seven Bridges Genomics

• Geneious (Dotmatics)

• CLC bio (QIAGEN)

• Genomatix Software GmbH

• Affymetrix (Thermo Fisher Scientific)

• SOPHiA GENETICS

• Benchling

• Strand Life Sciences

• Metabolon, Inc.